Strs Ohio Intra Cellular Therapies, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Strs Ohio holds 16,799 shares of ITCI stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,799

Previous 15,953 5.3%

Holding current value

$1.47 Million

Previous $1.09 Million 12.45%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$67.99 - $80.84 $57,519 - $68,390	846 Added 5.3%	16,799 $1.23 Million
Q2 2024 Aug 05, 2024	SELL	$64.76 - $79.84 $508,171 - $626,504	-7,847 Reduced 32.97%	15,953 $1.09 Million
Q1 2024 May 13, 2024	SELL	$64.37 - $75.65 $160,925 - $189,125	-2,500 Reduced 9.51%	23,800 $1.65 Million
Q4 2023 Jan 30, 2024	SELL	$46.37 - $73.65 $74,192 - $117,840	-1,600 Reduced 5.73%	26,300 $1.88 Million
Q3 2023 Oct 26, 2023	BUY	$52.09 - $64.1 $46,881 - $57,689	900 Added 3.33%	27,900 $1.45 Million
Q2 2023 Jul 31, 2023	BUY	$54.67 - $66.44 $344,421 - $418,572	6,300 Added 30.43%	27,000 $1.71 Million
Q1 2023 Aug 02, 2023	SELL	$43.8 - $56.99 $275,940 - $359,037	-6,300 Reduced 23.33%	20,700 $1.12 Million
Q1 2023 Apr 27, 2023	SELL	$43.8 - $56.99 $39,420 - $51,291	-900 Reduced 4.17%	20,700 $1.12 Million
Q4 2022 Jan 26, 2023	SELL	$44.07 - $54.45 $409,851 - $506,385	-9,300 Reduced 30.1%	21,600 $1.14 Million
Q2 2022 Jul 25, 2022	BUY	$43.0 - $65.64 $774,000 - $1.18 Million	18,000 Added 139.53%	30,900 $1.76 Million
Q1 2022 Apr 21, 2022	BUY	$38.74 - $62.09 $178,204 - $285,614	4,600 Added 55.42%	12,900 $789,000
Q4 2021 Jan 24, 2022	BUY	$35.2 - $53.42 $31,680 - $48,078	900 Added 12.16%	8,300 $434,000
Q2 2021 Jul 26, 2021	BUY	$29.3 - $44.5 $216,820 - $329,300	7,400 New	7,400 $302,000
Q4 2020 Jan 25, 2021	SELL	$23.34 - $32.22 $67,686 - $93,438	-2,900 Closed	0 $0
Q3 2020 Dec 14, 2020	SELL	$17.61 - $31.86 $35,220 - $63,720	-2,000 Reduced 40.82%	2,900 $74,000
Q2 2020 Jul 23, 2020	BUY	$14.35 - $26.64 $70,315 - $130,536	4,900 New	4,900 $125,000

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

85M

Call Options Held

299K

Put Options Held

130K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.27B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account